Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.

Abstract

OBJECTIVES:

To evaluate the role of trkA receptor as a potential tumor marker in serous epithelial ovarian cancer and its relationship with the angiogenic factors expression as vascular endothelial growth factor (VEGF) and nerve growth factor (NGF). Additionally, to examine whether NGF and VEGF secreted by epithelial ovarian cancer (EOC) explants and from epithelial ovarian cancer cell line (A2780) are involved in the process of angiogenesis, such as cellular proliferation, migration and differentiation of the human endothelial cell line (EA.hy926).

METHODS:

The mRNA levels of VEGF, NGF and trkA receptors were measured using PCR in 60 ovarian samples. Cellular localization and semi-quantitative estimation of VEGF, NGF, total trkA and p-trkA was performed using IHC in epithelial cells. NGF, total trkA and p-trkA protein were also evaluated in endothelial cells from the same tissues. Human endothelial cell line EA.hy926 was cultured with conditioned media obtained from both EOC explants and from the A2780 cell line, with or without NGF stimulus.

RESULTS:

Significantly higher levels of NGF, total trkA and p-trkA protein expressions were observed in epithelial and endothelial cells in poorly differentiated EOC versus normal ovary. Interestingly, the p-trkA receptor expression level showed the most significant difference and its presence was only found in borderline tumor and EOC samples indicating the importance of trkA receptor in EOC as a potential tumor marker. A significant increase in proliferation, migration and differentiation of EA.hy926 cells was observed with NGF, and this effect was significantly reverted when NGF was immuno-blocked and when a trkA inhibitor was used, showing that NGF is an important angiogenic factor in EOC by activating its trkA receptor.

CONCLUSION:

These results indicate that p-trkA may be considered as a new potential tumor marker in EOC, and that NGF may also act as a direct angiogenic factor in EOC.

• Authors: Verónica Tapia, Fernando Gabler, Marcela Muñoz, Roberto Yazigi, Alfonso Paredes, Alberto Selman, Margarita Vega, Carmen Romero
• Journal: Gynecologic oncology (Gynecol Oncol) Vol. 121 Issue 1 Pg. 13-23 (Apr 2011) ISSN: 1095-6859 [Electronic] United States
• PMID: 21236475 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2010 Elsevier Inc. All rights reserved.

Chemical References

• Biomarkers, Tumor
• RNA, Messenger
• VEGFA protein, human
• Vascular Endothelial Growth Factor A
• Nerve Growth Factor
• Receptor, trkA

Topics

• Aged
• Biomarkers, Tumor (biosynthesis, genetics)
• Carcinoma, Ovarian Epithelial
• Cell Differentiation (physiology)
• Cell Growth Processes (physiology)
• Cell Line, Tumor
• Cell Movement (physiology)
• Female
• Humans
• Immunohistochemistry
• Middle Aged
• Neoplasms, Glandular and Epithelial (enzymology, genetics, pathology)
• Nerve Growth Factor (biosynthesis, genetics)
• Ovarian Neoplasms (enzymology, genetics, pathology)
• RNA, Messenger (biosynthesis, genetics)
• Receptor, trkA (biosynthesis, genetics)
• Vascular Endothelial Growth Factor A (biosynthesis, genetics)